
Biosurgery
Description
Global Biosurgery Market to Reach US$18.4 Billion by 2030
The global market for Biosurgery estimated at US$14.5 Billion in the year 2024, is expected to reach US$18.4 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Hemostatic Agents segment is estimated at 3.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 3.9% CAGR
The Biosurgery market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.
strong>Global Biosurgery Market - Key Trends and Drivers Summarized
What Is Biosurgery, and Why Is It Gaining Traction in Modern Medicine?
Biosurgery is an innovative and rapidly evolving field within medical technology, but what exactly does it encompass? Broadly speaking, biosurgery involves the use of biologically-based or biocompatible materials to aid in surgical procedures. These materials are engineered to interact seamlessly with the human body, promoting healing, minimizing complications, and often providing alternatives to traditional surgical methods. The scope of biosurgery is extensive, covering areas such as hemostasis (the process of stopping bleeding), tissue regeneration, and even the use of bioactive implants that can integrate with living tissues. The growing emphasis on less invasive procedures, combined with the desire for faster recovery times and reduced hospital stays, has significantly increased interest in biosurgical techniques. As healthcare systems across the globe prioritize patient outcomes and cost-effectiveness, biosurgery is poised to become a cornerstone of modern surgical practice.
How Are Cutting-Edge Technologies Shaping the Future of Biosurgery?
The landscape of biosurgery is being dramatically transformed by advancements in technology, but how exactly are these changes unfolding? One of the most significant developments has been in the field of regenerative medicine, where biosurgical products such as scaffolds and growth factors are used to facilitate the repair or replacement of damaged tissues. Additionally, the integration of nanotechnology is allowing for the creation of more sophisticated biomaterials that can deliver drugs or other therapeutic agents directly to the site of surgery, enhancing the body`s natural healing processes. Robotics and imaging technologies are also playing a crucial role, providing surgeons with unprecedented precision and control during procedures. Furthermore, the advent of 3D printing is opening up new possibilities for custom implants and grafts that are tailored to individual patients, reducing the risk of rejection and improving outcomes. As these technologies continue to evolve, the potential applications of biosurgery are expanding, promising to revolutionize the way surgeries are performed.
Why Is Biosurgery Becoming the Go-To Option for Complex Surgical Cases?
The unique capabilities of biosurgical products are driving their adoption in complex and challenging surgical cases, but what makes them so indispensable? In many instances, traditional surgical methods are either too invasive or unable to achieve the desired outcomes, particularly in cases involving extensive tissue damage or delicate structures. Biosurgical products, such as fibrin sealants, collagen-based matrices, and synthetic grafts, provide surgeons with tools that can enhance the body`s natural ability to heal, reduce the risk of complications, and improve the overall success rate of surgeries. For example, in cardiovascular surgery, biosurgery is playing a pivotal role in the repair of blood vessels and the prevention of excessive bleeding. In orthopedic surgery, bioactive materials are being used to promote bone regeneration and improve the integration of implants. Moreover, biosurgery is finding increasing applications in wound care, particularly in chronic wounds that are resistant to conventional treatments. As the healthcare industry continues to grapple with the challenges of an aging population and the rising prevalence of chronic diseases, the role of biosurgery in managing these conditions is set to grow.
What Is Fueling the Rapid Expansion of the Biosurgery Market?
The growth in the biosurgery market is driven by several factors, each contributing to the increasing demand for these advanced surgical solutions. Technological innovations, particularly in biomaterials and regenerative medicine, have significantly expanded the range of applications for biosurgery, making it a more viable option across various medical disciplines. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is leading to an increase in complex surgical cases where traditional methods may fall short. Consumer behavior is also playing a role, with patients increasingly seeking out minimally invasive procedures that offer quicker recovery times and fewer side effects. The growing awareness and acceptance of biosurgery among healthcare providers further drive its adoption, as more clinicians recognize the benefits of these techniques in improving patient outcomes. Moreover, the aging global population is contributing to the demand for biosurgical products, as older patients are more likely to require surgical interventions that benefit from these advanced technologies. Finally, supportive government policies and increased investment in healthcare infrastructure, particularly in emerging markets, are providing the necessary environment for the biosurgery market to thrive, ensuring continued growth and innovation in this exciting field.
SCOPE OF STUDY:The report analyzes the Biosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents, Anti-Adhesion Agents); Application (General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications); End-Use (Hospitals, Clinics, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 12 Featured) -
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Baxter International, Inc.
- Cohera Medical, Inc.
- CryoLife, Inc.
- Hemostasis, LLC
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- MAQUET Holding B.V. & Co. KG
- Medtronic PLC
- Pfizer, Inc.
- Sanofi U.S.
- Stryker Corporation
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Biosurgery – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Demand for Minimally Invasive Surgeries Spurs Growth in Biosurgery Market
- Advancements in Biomaterials and Tissue Engineering Expand Addressable Market Opportunity
- Increased Use of Biosurgery in Cardiovascular and Orthopedic Procedures Drives Market Adoption
- Here`s How Technological Innovations in Hemostasis and Sealants Propel Market Growth
- Growing Geriatric Population and Associated Chronic Conditions Generate Demand for Biosurgical Products
- Emerging Applications of Biosurgery in Regenerative Medicine Sustain Long-Term Market Expansion
- Shifts Towards Personalized Medicine and Customized Surgical Solutions Throw the Spotlight on Biosurgery
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 44: USA Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: USA 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 50: USA Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: USA Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: USA 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- CANADA
- TABLE 53: Canada Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Canada 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 59: Canada Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Canada Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Canada 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- JAPAN
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 62: Japan Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Japan 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 68: Japan Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Japan Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Japan 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- CHINA
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 71: China Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: China 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 77: China Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: China Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: China 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- EUROPE
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 80: Europe Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 89: Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- FRANCE
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 92: France Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: France 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 98: France Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: France Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: France 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- GERMANY
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 101: Germany Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Germany 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 107: Germany Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Germany Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Germany 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- ITALY
- TABLE 110: Italy Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: Italy 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 116: Italy Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: Italy Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: Italy 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 119: UK Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: UK 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 125: UK Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: UK Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: UK 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Rest of Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Rest of Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Rest of Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Rest of Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Rest of Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Asia-Pacific Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Asia-Pacific Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: Asia-Pacific 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Asia-Pacific Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: Asia-Pacific 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF WORLD
- TABLE 146: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of World Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
- TABLE 149: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of World Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Rest of World 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
- TABLE 152: Rest of World Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Rest of World Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Rest of World 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates